Evidence map›Paper›PMID 36830145›Full record

ReviewAntibiotics (Basel, Switzerland)2023

Carbapenem-Resistant

Theodoros Karampatakis, Katerina Tsergouli, Payam Behzadi

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 222 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed, 4 pooled it
27.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

222 citing papers in PubMed, 4 syntheses or guidelines pooled it, 287 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Incidence of carbapenemase-resistant isolates ofNew microbes and new infections · 2026
    Article
  15. Review
  16. Article
  17. Multicenter Point-Prevalence Study of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  18. Article
  19. High burden of blaBMC microbiology · 2026
    Article
  20. Article

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Theodoros KarampatakisMicrobiology Department, Papanikolaou General Hospital, 57010 Thessaloniki, Greece.ORCID 0000-0003-0928-3193
Katerina TsergouliMicrobiology Department, Agios Pavlos General Hospital, 55134 Thessaloniki, Greece.ORCID 0000-0001-6552-1585
Payam BehzadiDepartment of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran 37541-374, Iran.ORCID 0000-0001-5441-3976
Agios Pavlos General Hospital · GRG. Papanikolaou General Hospital · GRIslamic Azad University, Shahr-e-Qods Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial agentscarbapenem-resistant Klebsiella pneumoniaemolecular epidemiologyvirulence factors

Identifiers

PMID36830145
PMCPMC9952820
OpenAlexW4317931744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.